Labcorp expanded its partnership with PathAI to offer its FDA-cleared digital pathology platform at the life science giant’s U.S. network of anatomical pathology labs and participating hospitals.
Labcorp (NYSE:LH) executives said the company delivered what CEO Adam Schechter called a “very strong year” in 2025, citing ...
StockStory.org on MSN
Labcorp (LH) to report earnings tomorrow: Here is what to expect
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) will be announcing earnings results this Tuesday before market hours. Here’s what investors should know. Labcorp met analysts’ revenue ...
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced an expanded collaboration with PathAI to deploy AISight® Dx 1, an FDA-cleared digital pathology ...
LH heads into its Q4 earnings report with rising revenue and EPS expectations, driven by Diagnostics momentum, acquisitions ...
InvestorsHub on MSN
Labcorp tops Q4 profit forecasts but revenue slightly misses
Labcorp Holdings Inc. (NYSE:LH) delivered fourth-quarter adjusted earnings above expectations on Tuesday, though revenue came ...
Feb 17 (Reuters) - Laboratory services provider Labcorp forecast annual profit above Wall Street estimates on Tuesday, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results